| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.26▼ | 1.26▼ | 1.26▼ | 1.24▲ | 1.27 |
| MA10 | 1.27▼ | 1.27▼ | 1.27▼ | 1.27▲ | 1.32▼ |
| MA20 | 1.29▼ | 1.29▼ | 1.30▼ | 1.27▲ | N/A |
| MA50 | 1.27▼ | 1.28▼ | 1.28▼ | 1.30▼ | N/A |
| MA100 | 1.32▼ | 1.31▼ | N/A | N/A | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.005▼ | -0.004▼ | -0.003▼ | -0.001▼ | N/A |
| RSI | 46.430▼ | 46.500▼ | 46.636▼ | 49.023▼ | N/A |
| STOCH | 30.913 | 30.913 | 30.913 | 23.048 | N/A |
| WILL %R | -75.000▼ | -75.000▼ | -75.000▼ | -60.000 | N/A |
| CCI | -44.674 | -44.674 | -44.674 | -21.271 | N/A |
|
Wednesday, September 16, 2026 05:29 AM
PMA Graphene Technology Group Inc. (the “Company” or “PMA”) (NASDAQ: PMA), a Hong Kong-based company mainly engaged in wet trades works whose mission it is to become the leading wet trades works ...
|
|
Thursday, September 10, 2026 07:14 AM
Detailed price information for Pma Graphene Technology Group Inc (PMA-Q) from The Globe and Mail including charting and trades.
|
|
Wednesday, August 19, 2026 07:37 AM
Femasys has received FDA approval to use a modular premarket approval submission process for FemBloc, giving the company a defined regulatory framework as its pivotal U.S. clinical trial continues.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 09/10/26 | 1.26 | 1.2896 | 1.2549 | 1.27 | 12,386 |
| 08/10/26 | 1.26 | 1.26 | 1.23 | 1.25 | 3,742 |
| 07/10/26 | 1.19 | 1.26 | 1.19 | 1.26 | 10,006 |
| 06/10/26 | 1.20 | 1.26 | 1.20 | 1.23 | 17,609 |
| 05/10/26 | 1.21 | 1.2201 | 1.20 | 1.20 | 8,488 |
| 02/10/26 | 1.31 | 1.31 | 1.23 | 1.23 | 3,925 |
| 01/10/26 | 1.25 | 1.305 | 1.25 | 1.30 | 6,946 |
| 30/09/26 | 1.30 | 1.3399 | 1.30 | 1.30 | 3,496 |
| 29/09/26 | 1.31 | 1.35 | 1.30 | 1.35 | 6,622 |
| 28/09/26 | 1.34 | 1.34 | 1.3001 | 1.302 | 7,393 |
|
|
||||
|
|
||||
|
|